Dr. Metcalfe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1001 Potrero Ave RM 5k1
San Francisco, CA 94110Phone+1 415-206-4679
Education & Training
- University of California, BerkeleyPhD, Epidemiology, 2008
- University of California, BerkeleyBoard Certifications, Internal Medicine, Pulmonary Medicine, Critical Care Medicine, 2007 - 2009
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 2006 - 2009
- University of California (San Francisco)Residency, Pulmonary Disease and Critical Care Medicine, 2006 - 2009
- University of California (San Francisco)Residency, Internal Medicine, 2003 - 2006
- Tufts University School of MedicineMPH, Medicine, International Health, 1998 - 2003
- Tufts University School of MedicineClass of 2003
- Humboldt State UniversityBS, Molecular Biology, 1995 - 1998
Certifications & Licensure
- CA State Medical License 2005 - 2026
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Chancellor’s Fellowship for Graduate Education University of California, Berkeley, CA, 2008, 2009, 2010
- Robert Wood Johnson Medical Faculty Development Award, Semifinalist 2008, 2009
- Tufts University School of Medicine Half-Tuition Scholarship 1998-2002, 2003
- Join now to see all
Clinical Trials
- Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study Start of enrollment: 2021 Jun 16
Publications & Presentations
PubMed
- Xpert MTB/RIF Ultra-resistant and MTBDRsusceptible rifampicin results in people with tuberculosis: utility of FluoroType MTBDR and deep sequencing.Yonas Ghebrekristos, Aysha Ahmed, Natalie Beylis, Sarishna Singh, Christoffel Opperman
Antimicrobial Agents and Chemotherapy. 2025-02-07 - URAdime - a tool for analyzing primer sequences in sequencing data to identify dimers and super-amplicons.Jason D Limberis, John Z Metcalfe
Biorxiv. 2025-01-28 - spotPCR: A Rapid and Efficient Approach for Indexing Individual Template Molecules using Unique Molecular Identifiers.Jason D Limberis, Roland J Nagel, Soumitesh Chakravorty, Dena Block, Scot Dewell
Biorxiv. 2024-12-12
Journal Articles
- Endemic malaria in the Peruvian Amazon region of Iquitos.Roshanravan B, Kari E, Gilman RH, Cabrera L, Lee E, Metcalfe J, Calderon M, Lescano AG, Montenegro SH, Calampa C, Vinetz JM, Am J Trop Med Hyg
- Leptospirosis–associated Severe Pulmonary Hemorrhage Syndrome, Salvador, Brazil.Gouveia EL, Metcalfe J, de Carvalho AL, Aires TS, Villasboas-Bisneto JC, Queirroz A, Santos AC, Salgado K, Reis MG, Ko AI, Emerg Infect Dis
- Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.Gopal M, Padayatchi N, Metcalfe J, O’donnell M, Int J Tub Lung Dis
- Join now to see all
Press Mentions
- TGen Sequencing Test Enables Precise Identification of Drug-Resistant TBOctober 9th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: